Nextmune News and Activities

Nextmune is owned by Vimian Group. Vimian Group has a direct presence in 11 countries.

Vimian Group has 16 subsidiaries including dvmGRO, Movora and Nextmune.

They are in:

• Healthcare94%
• Biotechnology6%

View the org chart displaying its 7 main executives

Most searched biographies at Nextmune

• Joana Leite, Country Manager, Benelux, DACH & Nordics
• Andrea Baldacci, Operations Manager
• Frederic Alles, Business Development Manager

Popular executive movements at Nextmune

• Magnus Kjellberg, who is Chief Executive Officer will soon leave the company  (posted on January 14 2026).

Popular executive movements at Vimian Group

• Lotta Lundas will join the company as Head of MedTech and member of Group Management on Apr. 13, 2026  (posted on March 16 2026).
• Mathias Carlsson has joined the company as Head of Financial Control  (posted on January 13 2026).
• Carl-Johan Zetterberg who was Interim Chief Executive Officer, becomes Chief Financial Officer  (posted on November 25 2025).

Click here to view some more movements at Vimian Group

Create your alert
to follow the executive moves at Nextmune.

Vimian Group has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Nextmune

• House Dust Mite: Not Just an Indoor Problem
• Comparative Accuracy of 6 U.S. Allergy Panels
• Early Probiotic Exposure Has Long-Term Effects in Atopic Dogs
• From Seasonal Pruritus to Long-Term Immune Control
• Topicals as an Antibiotic-Sparing Strategy in Veterinary Dermatology
• Now available: PAX Pet Parent Report
• Allergen-Specific Immunotherapy (ASIT): A Disease-Modifying Option for Feline Atopic Syndrome
• View more press releases Close

Social media about Nextmune

• Nextmune on Wikipedia, Google News & Yahoo Finance
• Nextmune on LinkedIn, X (Twitter) & YouTube